Melanoma, Melanin, and Melanogenesis: The Yin and Yang Relationship.
Melanoma, Melanin, and Melanogenesis: The Yin and Yang Relationship.
复制标题
DOI:
10.3389/fonc.2022.842496
复制
发表时间:
2022
影响因子:
4.7
通讯作者:
Slominski AT
中科院分区:
文献类型:
--
作者:
Slominski RM;Sarna T;Płonka PM;Raman C;Brożyna AA;Slominski AT
Melanin pigment plays a critical role in the protection against the harmful effects of ultraviolet radiation and other environmental stressors. It is produced by the enzymatic transformation of L-tyrosine to dopaquinone and subsequent chemical and biochemical reactions resulting in the formation of various 5,6-dihydroxyindole-2-carboxylic acid (DHICA) and 5,6-dihydroxyindole (DHI) oligomers—main constituents of eumelanin, and benzothiazine and benzothiazole units of pheomelanin. The biosynthesis of melanin is regulated by sun exposure and by many hormonal factors at the tissue, cellular, and subcellular levels. While the presence of melanin protects against the development of skin cancers including cutaneous melanoma, its presence may be necessary for the malignant transformation of melanocytes. This shows a complex role of melanogenesis in melanoma development defined by chemical properties of melanin and the nature of generating pathways such as eu- and pheomelanogenesis. While eumelanin is believed to provide radioprotection and photoprotection by acting as an efficient antioxidant and sunscreen, pheomelanin, being less photostable, can generate mutagenic environment after exposure to the short-wavelength UVR. Melanogenesis by itself and its highly reactive intermediates show cytotoxic, genotoxic, and mutagenic activities, and it can stimulate glycolysis and hypoxia-inducible factor 1-alpha (HIF-1α) activation, which, combined with their immunosuppressive effects, can lead to melanoma progression and resistance to immunotherapy. On the other hand, melanogenesis-related proteins can be a target for immunotherapy. Interestingly, clinicopathological analyses on advanced melanomas have shown a negative correlation between tumor pigmentation and diseases outcome as defined by overall survival and disease-free time. This indicates a “Yin and Yang” role for melanin and active melanogenesis in melanoma development, progression, and therapy. Furthermore, based on the clinical, experimental data and diverse effects of melanogenesis, we propose that inhibition of melanogenesis in advanced melanotic melanoma represents a realistic adjuvant strategy to enhance immuno-, radio-, and chemotherapy.
登录
查看更多内容
影响因子:
5.6
作者:
Brożyna AA;Jochymski C;Janjetovic Z;Jóźwicki W;Tuckey RC;Slominski AT
通讯作者:
Slominski AT
影响因子:
1.5
作者:
Brash DE
通讯作者:
Brash DE
影响因子:
3.4
作者:
BRUENGER, FW;STOVER, BJ;ATHERTON, DR
通讯作者:
ATHERTON, DR
DOI:
10.1016/b978-0-12-397927-8.00004-x
发表时间:
2012
期刊:
Advances in pharmacology (San Diego, Calif.)
影响因子:
--
作者:
Bailey, Kate M;Wojtkowiak, Jonathan W;Hashim, Arig Ibrahim;Gillies, Robert J
通讯作者:
Gillies, Robert J
影响因子:
2
作者:
Brozyna, Anna A.;Hoffman, Robert M.;Slominski, Andrzej T.
通讯作者:
Slominski, Andrzej T.